Meet up with us at Booth 531 or at multiple talks and presentations throughout the…
Peterson Health Technology Institute just released a first-of-its-kind digital health value assessment report on the…
Seeking multiple positions to join our team, including a Director of Evidence Synthesis!
The Journal of Managed Care & Specialty Pharmacy recently published a systematic review by one…
Happy New Year! We are excited about what 2024 has in store.
An article co-authored by Sean D. Sullivan, Curta Partner and President, was one of three…
This budget impact analysis of nirmatrelvir/ritonavir (NMV/r) for treating mild-to-moderate COVID-19 at high-risk of severe…
This cost-effectiveness analysis of nirmatrelvir/ritonavir (NMV/r) vs. best supportive care for treating mild-to-moderate COVID-19 in…
The U.S. Inflation Reduction Act enabled CMS to negotiate Medicare drug prices. In this commentary,…
This meta-analysis of 224 studies on colorectal cancer (CRC) reveals a 4.1% HER2 positivity (HER2+)…
Curta was selected to bring our decades of experience in HEOR to an initiative of…
In this worked example using Curta’s Oncology Simulation Model (OSM) framework, Curta researchers examined the…
